Stockreport

Biosimilars Market to grow by USD 54.35 billion (2024-2028), cost advantage over biologics to drive revenue, Report with the AI impact on market trends - Technavio [Yahoo! Finance]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF The market is estimated to grow at a CAGR of almost 23.63% during the forecast period. Price advantage of biosimilars over biologics is driving market growth, with a tre [Read more]